Nonsecretory immunoglobulin-derived amyloidosis of the heart: Diagnosis by immunohistochemistry of the endomyocardium
- 1 May 1997
- journal article
- case report
- Published by Wiley in Clinical Cardiology
- Vol. 20 (5) , 494-496
- https://doi.org/10.1002/clc.4960200518
Abstract
Primary amyloid light chain (AL) amyloidosis of the heart is a rare cause of congestive heart failure. Approximately 15% of patients with primary AL amyloidosis demonstrate no monoclonal proteins on serum or urine immunoelectrophoresis (so‐called nonsecretory immunoglobulin‐derived amyloidosis). The histologic findings of endomyocardial biopsy from these patients may be indistinguishable from those with senile cardiac amyloidosis. However, the AL type may respond favorably to chemotherapy while the latter type does not. The prognosis is also better in the senile cardiac amyloid type. The precise diagnosis in the present case was made by applying immunohistochemical techniques on cardiac tissues.Keywords
This publication has 8 references indexed in Scilit:
- Amyloidosis and endomyocardial biopsy: Correlation of extent and pattern of deposition with amyloid immunophenotype in 100 casesCardiovascular Pathology, 1995
- Amyloidosis: Prognosis and treatmentSeminars in Arthritis and Rheumatism, 1994
- Cardiac amyloidosis: a review and report of a new transthyretin (prealbumin) variant.Heart, 1993
- Prognostic significance of Doppler measures of diastolic function in cardiac amyloidosis. A Doppler echocardiography study.Circulation, 1991
- Beta2-microglobulin predicts survival in primary systemic amyloidosisThe American Journal of Medicine, 1990
- Primary Systemic Amyloidosis—a Diagnostic PrimerMayo Clinic Proceedings, 1989
- Senile Cardiac Amyloidosis with Myocardial DysfunctionNew England Journal of Medicine, 1987
- Clinical Significance of Histopathologic Patterns of Cardiac AmyloidosisMayo Clinic Proceedings, 1984